Novel insights into circular RNA regulation in arsenic-exposure- induced lung cancer

被引：5
作者：
Ao, Xiang [1 ]
Liu, Ying [1 ,2 ]
机构：
[1] Qingdao Univ, Qingdao Med Coll, Sch Basic Med Sci, Qingdao 266071, Peoples R China
[2] Qingdao Univ, Affiliated Hosp, Inst Translat Med, Qingdao Med Coll, Qingdao 266021, Peoples R China
来源：
MOLECULAR THERAPY ONCOLYTICS | 2022年 / 27卷
基金：
中国博士后科学基金;
关键词：
D O I：
10.1016/j.omto.2022.10.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 202
页数：3
相关论文
共 5 条
[1]   A review of low-dose arsenic risks and human cancers [J].
Lamm, Steven H. ;
Boroje, Isabella J. ;
Ferdosi, Hamid ;
Ahn, Jaeil .
TOXICOLOGY, 2021, 456
[2]   The pivotal regulatory factor circBRWD1 inhibits arsenic exposure-induced lung cancer occurrence by mRNA and its stability [J].
Li, Xiaofei ;
Chen, Sixian ;
Wang, Xin ;
Zhang, Ruirui ;
Yang, Jialei ;
Xu, Haotian ;
He, Wanting ;
Lai, Mingshuang ;
Wu, Shuilian ;
Nan, Aruo .
MOLECULAR THERAPY-ONCOLYTICS, 2022, 26 :399-412
[3]   FOXO3a in cancer drug resistance [J].
Liu, Ying ;
Wang, Yu ;
Li, Xiaoge ;
Jia, Yi ;
Wang, Jianxun ;
Ao, Xiang .
CANCER LETTERS, 2022, 540
[4]   Biogenesis, functions, and clinical implications of circular RNAs in non-small cell lung cancer [J].
Liu, Ying ;
Ao, Xiang ;
Yu, Wanpeng ;
Zhang, Yuan ;
Wang, Jianxun .
MOLECULAR THERAPY NUCLEIC ACIDS, 2022, 27 :50-72
[5]   Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications [J].
Zhou, Xuehao ;
Ao, Xiang ;
Jia, Zhaojun ;
Li, Yiwen ;
Kuang, Shouxiang ;
Du, Chengcheng ;
Zhang, Jinyu ;
Wang, Jianxun ;
Liu, Ying .
FRONTIERS IN ONCOLOGY, 2022, 12
1